tiprankstipranks
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Canadian Market

HLS Therapeutics Inc (HLS) Financial Statements

Compare
44 Followers

HLS Therapeutics Inc Financial Overview

HLS Therapeutics Inc's market cap is currently C$151.02M. The company's EPS TTM is C$-0.842; its P/E ratio is ―; HLS Therapeutics Inc is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is C$-0.17. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 56.62M$ 63.07M$ 61.47M$ 60.01M$ 56.11M
Gross Profit$ 47.62M$ 55.45M$ 56.49M$ 56.04M$ 52.48M
Operating Income$ 0.00$ -10.35M$ -13.44M$ -6.24M$ -11.26M
EBITDA$ 17.22M$ 12.88M$ 18.00M$ 25.41M$ 23.19M
Net Income$ -19.66M$ -27.53M$ -23.60M$ -13.12M$ -15.33M
Balance Sheet
Cash & Short-Term Investments$ 17.46M$ 21.95M$ 20.72M$ 21.18M$ 20.61M
Total Assets$ 159.90M$ 209.06M$ 241.65M$ 275.90M$ 303.91M
Total Debt$ 66.45M$ 87.62M$ 97.34M$ 97.57M$ 107.12M
Net Debt$ 48.99M$ 65.67M$ 76.62M$ 76.39M$ 86.51M
Total Liabilities$ 88.56M$ 111.36M$ 116.33M$ 115.17M$ 134.66M
Stockholders' Equity$ 71.34M$ 97.70M$ 125.32M$ 160.74M$ 169.25M
Cash Flow
Free Cash Flow$ 7.99M$ 15.60M$ 6.79M$ 11.92M$ -35.33M
Operating Cash Flow$ 8.00M$ 15.79M$ 16.94M$ 16.43M$ 9.34M
Investing Cash Flow$ 11.73M$ -189.00K$ -10.15M$ -4.51M$ -44.68M
Financing Cash Flow$ -23.36M$ -14.64M$ -6.86M$ -11.40M$ 9.56M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

HLS Therapeutics Inc Debt to Assets

HLS Therapeutics Inc Cash Flow

HLS Therapeutics Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis